SOMNF

Healthcare Medical Devices

SomnoMed Limited

$0.43
+0.19 +77.50% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 6, 2026, live at 11:08 AM ET0.43

Key Stats

Market Cap
93.62M
Avg Volume
26
EPS
-$0.01
52W High
$0.51
52W Low
$0.24
Div. Yield
0.0%

Valuation

P/B Ratio
2.84
P/S Ratio
0.82
EV/EBITDA
13.54
EV/Revenue
0.36

Margins

Gross Margin 61.1%
Operating Margin (3.4%)
Net Margin (2.3%)
EBITDA Margin 2.6%

Growth & Returns

Revenue Growth (YoY)
(6.9%)
Return on Equity
(5.7%)
Return on Assets
0.8%

Liquidity & Leverage

Current Ratio
1.67
Quick Ratio
1.24
Debt / Equity
0.12
Total Cash
17.18M
Total Debt
5.46M

About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.

somnomed.com/au/